Akribion Therapeutics exits from stealth with €8m seed financing

Akribion is pioneering a unique, RNA-guided, nuclease-based technology for programmable cell depletion

06-Feb-2025 - Akribion Therapeutics, the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, announces its exit from stealth and the completion of a Seed Financing round raising EUR 8 million to accelerate the development of novel therapeutics based ...

Side-effect free RNA therapeutics active only in diseased cells

SRTD biotech secures seed financing

18-Nov-2024 - Jülich-based biotech start-up SRTD biotech GmbH has successfully closed a seven-figure seed financing round. The company will use the fresh capital to accelerate the development of novel RNA therapeutics. Based on a proprietary platform technology, SRTD biotech aims to develop highly efficient ...

Successful exit: adivo joins Zoetis

adivo’s team and platform will strengthen Zoetis’ capabilities in therapeutic antibody drug discovery for companion animals

19-Sep-2023 - adivo GmbH, a leader in discovering species-specific therapeutic antibodies for pets, announced that it is part of Zoetis, the world’s leading animal health company. HTGF and the existing investors OCCIDENT and MorphoSys AG sold their shares as part of the deal. HTGF was one of the first ...

First generation of real microbiome-based therapeutics

Microbiome therapeutics biotech mbiomics raises EUR 13 million in first closing of Series A round

28-Mar-2023 - mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced the first closing of EUR13 million (US$ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the ...

Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics

21-Feb-2022 - Biograil ApS, a Copenhagen based biotech startup developing a unique oral device for delivery of biologics that would otherwise be injected, announced the closing of a Seed 2 funding of 3.2 million Euro. The Round was led by Danish Megatrend Invest a/s with strong support from other prior ...

Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs  

13-Jan-2022 - Pantherna Therapeutics announces the successful completion of a follow-on financing round totaling EUR 4.0 Mio. led by existing investors Riesner Verwaltungs GmbH and High-Tech Gründerfonds. The proceeds of this round will be used to accelerate preclinical development activities for its lead ...

Advance Gene Therapy Pipeline for Musculoskeletal Diseases

GeneQuine Biotherapeutics Secures more than €9 Million

28-Jan-2021 - GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A ...

Emergence Therapeutics Announces a Bumped-up Follow-on Seed Round Financing

Financing enables company to embark on additional targets and expand ADC technology reach

27-Nov-2020 - Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that is has closed a Bumped-up Follow-on Seed Round Financing from a syndicate of leading European investors comprising ...

Biograil secures seed funding for oral delivery device with potential to transform market for injectables

21-Jan-2020 - Biograil ApS, an innovative biotechnology company developing a unique oral device for delivery of biologics that would otherwise be injected, announced the closing of a seed funding of 3 Million Euro (with potential to expand to 5 Million Euro). The investor Syndicate was led by the experienced ...

Chemistry-for-Healthcare Start-up secures seed investment

18-Sep-2019 - Belyntic, a Berlin-based chemistry-for-healthcare startup and developer of the Peptide Easy Clean (PEC) purification technology, has completed its seed financing round amounting to €1.3 million. The funding is led by the Investitionsbank Berlin (IBB), with the High-Tech Gründerfonds (HTGF) also ...